SCHEMBL2808864

SCHEMBL2808864

CC/C(=C\Oc1ccccc1OC)C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
POLB P06746 2/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
PLIN1 O60240 1/20 0.42
PLIN5 Q00G26 1/20 0.42
KMT2A Q03164 1/20 0.42
ABHD5 Q8WTS1 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MTNR1B P49286 3/20 0.42
HTT P42858 2/20 0.41
CTSD P07339 1/20 0.41
MTNR1A P48039 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA7 P43166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808867 1.00 NFE2L2 (0.43) NFE2L2SMN1; SMN2POLBLMNAMAPT
SCHEMBL2812376 0.86 POLB (0.47) NFE2L2SMN1; SMN2POLBLMNAMAPT
SCHEMBL2812380 0.86 POLB (0.47) NFE2L2SMN1; SMN2POLBLMNAMAPT
SCHEMBL2811036 0.81 NPSR1 (0.48) SMN1; SMN2POLBMEN1KMT2AHSD17B10
SCHEMBL2811039 0.81 NPSR1 (0.48) SMN1; SMN2POLBMEN1KMT2AHSD17B10
SCHEMBL2813106 0.81 RECQL (0.40) SMN1; SMN2MAPTMEN1KMT2AMTNR1B
SCHEMBL2813105 0.81 RECQL (0.40) SMN1; SMN2MAPTMEN1KMT2AMTNR1B
SCHEMBL2808836 0.78 MTNR1B (0.46) SMN1; SMN2POLBMAPTMEN1KMT2A
SCHEMBL2808833 0.78 MTNR1B (0.46) SMN1; SMN2POLBMAPTMEN1KMT2A
SCHEMBL2809198 0.78 GSK3B (0.44) SMN1; SMN2POLBKMT2AHTTCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 NFE2L2 252/4885SMN1; SMN2 1135/4885POLB 4283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.